Cargando…

Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study

BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsider...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Orazio, Beatrice, Geraci, Girolamo, Famà, Fausto, Terranova, Gloria, Di Vita, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610929/
https://www.ncbi.nlm.nih.gov/pubmed/34877311
http://dx.doi.org/10.12998/wjcc.v9.i32.9722
_version_ 1784603195306147840
author D'Orazio, Beatrice
Geraci, Girolamo
Famà, Fausto
Terranova, Gloria
Di Vita, Gaetano
author_facet D'Orazio, Beatrice
Geraci, Girolamo
Famà, Fausto
Terranova, Gloria
Di Vita, Gaetano
author_sort D'Orazio, Beatrice
collection PubMed
description BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM: To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS: We conducted a case-control study involving 30 male patients affected by CAF with hypertonic IAS who underwent fissurectomy and anoplasty with V-Y cutaneous flap advancement. The patients were divided into two groups: Those in group I underwent surgery alone, and those in group II underwent surgery and a botulinum toxin injection directly into the IAS. They were followed up for at least 2 years. The goals were to achieve complete healing of the patient and to assess the FI and recurrence rate along with manometry parameters. RESULTS: The intensity and duration of post-defecatory pain decreased significantly in both groups of patients starting with the first defecation, and this reduction was higher in group II. Forty days after surgery, we achieved complete wound healing in all the patients in group II but only in 80% of the patients in group I (P < 0.032). We recorded 2 cases of recurrence, one in each group, and both healed with conservative therapy. We recorded one temporary and low-grade postoperative case of “de novo” FI. Manometry parameters reverted to the normal range earlier for group II patients. CONCLUSION: The injection of botulinum toxin A in association with fissurectomy and anoplasty with a V-Y advancement flap improves the results of surgery alone in patients affected by CAF with IAS hypertonia.
format Online
Article
Text
id pubmed-8610929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-86109292021-12-06 Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study D'Orazio, Beatrice Geraci, Girolamo Famà, Fausto Terranova, Gloria Di Vita, Gaetano World J Clin Cases Case Control Study BACKGROUND: Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM: To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS: We conducted a case-control study involving 30 male patients affected by CAF with hypertonic IAS who underwent fissurectomy and anoplasty with V-Y cutaneous flap advancement. The patients were divided into two groups: Those in group I underwent surgery alone, and those in group II underwent surgery and a botulinum toxin injection directly into the IAS. They were followed up for at least 2 years. The goals were to achieve complete healing of the patient and to assess the FI and recurrence rate along with manometry parameters. RESULTS: The intensity and duration of post-defecatory pain decreased significantly in both groups of patients starting with the first defecation, and this reduction was higher in group II. Forty days after surgery, we achieved complete wound healing in all the patients in group II but only in 80% of the patients in group I (P < 0.032). We recorded 2 cases of recurrence, one in each group, and both healed with conservative therapy. We recorded one temporary and low-grade postoperative case of “de novo” FI. Manometry parameters reverted to the normal range earlier for group II patients. CONCLUSION: The injection of botulinum toxin A in association with fissurectomy and anoplasty with a V-Y advancement flap improves the results of surgery alone in patients affected by CAF with IAS hypertonia. Baishideng Publishing Group Inc 2021-11-16 2021-11-16 /pmc/articles/PMC8610929/ /pubmed/34877311 http://dx.doi.org/10.12998/wjcc.v9.i32.9722 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Control Study
D'Orazio, Beatrice
Geraci, Girolamo
Famà, Fausto
Terranova, Gloria
Di Vita, Gaetano
Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title_full Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title_fullStr Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title_full_unstemmed Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title_short Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study
title_sort botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: a case-control study
topic Case Control Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610929/
https://www.ncbi.nlm.nih.gov/pubmed/34877311
http://dx.doi.org/10.12998/wjcc.v9.i32.9722
work_keys_str_mv AT doraziobeatrice botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy
AT geracigirolamo botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy
AT famafausto botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy
AT terranovagloria botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy
AT divitagaetano botulinumtoxinassociatedwithfissurectomyandanoplastyforhypertonicchronicanalfissureacasecontrolstudy